Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients

Metabolism: Clinical and Experimental

Volumn 58, Issue 7, 2009, Pages 927-933

  Rossi, Rosario ^a   Nuzzo, Annachiara ^a   Guaraldi, Giovanni ^a   Squillace, Nicola ^a   Orlando, Gabriella ^a   Esposito, Roberto ^a   Lattanzi, Antonella ^a   Modena, Maria G ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INSULIN;

ADULT; AGED; ARTERY DIAMETER; ARTERY MALFORMATION; ARTICLE; BRACHIAL ARTERY ENLARGEMENT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; VASODILATATION;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRACHIAL ARTERY; FEMALE; HIV; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; YOUNG ADULT;

EID: 66349136188     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.02.026     Document Type: Article

References (26)

1. Waters L., and Nelson M. Long-term complications of antiretroviral therapy: lipoatrophy. Int J Clin Pract 61 (2007) 999-1014
2. de Saint Martin L., Pasquier E., Vandhuick O., Arnaud B., Vallet S., Duchemin J., et al. Correlations between carotid IMT, factor VIII activity level and metabolic disturbances: a cardio-vascular risk factor in the HIV positive persons. Curr HIV Res 5 (2007) 361-364
3. Mallon P.W. Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy. AIDS Rev 9 (2007) 3-15
4. Grinspoon S., and Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352 (2005) 48-62
5. Carr A., Samaras K., Burton S., Law M., Freund J., Chisholm D.J., et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12 (1998) 51-58
6. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and risk of myocardial infarction. N Engl J Med 349 (2003) 1993-2003
7. Fang C.T., Chang Y.Y., Hsu H.M., Twu S.J., Chen K.T., Lin C.C., et al. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM 100 (2007) 97-105
8. The DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 356 (2007) 1723-1735
9. Leow M.K., Addy C.L., and Mantzoros C.S. Human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies. J Clin Endocrinol Metab 88 (2003) 1961-1976
10. Jerico C., Knobel H., Montero M., Ordonez-Llanos J., Guelar A., Gimeno J.L., et al. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care 28 (2005) 132-137
11. Samaras K., Wand H., Law M., Emery S., Cooper D., and Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin-resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia. Diabetes Care 30 (2007) 113-119
12. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., and Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987) 1371-1375
13. Crouse J.R., Goldbourt U., Evans G., Pinsky J., Sharrett A.R., Sorlie P., et al. Arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort: in vivo quantification of carotid arterial enlargement. Stroke 25 (1994) 1354-1359
14. Steinke W., Els T., and Hennerici M. Compensatory carotid artery dilatation in early atherosclerosis. Circulation 89 (1994) 2578-2581
15. Pasterkamp G., Schoneveld A.H., Van Wolferen W., Hillen B., Clarijs R.J., Haudenschild C.C., et al. The impact of atherosclerotic arterial remodeling on percentage of luminal stenosis varies widely within the arterial system: a postmortem study. Arterioscler Thromb Vasc Biol 17 (1997) 3057-3063
16. Hamburg N.M., Larson M.G., Vita J.A., Vasan R.S., Keyes M.J., Widlansky M.E., et al. Metabolic syndrome, insulin-resistance, and brachial artery vasodilator function in Framingham offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol 101 (2008) 82-88
17. Holubkov R., Karas R.H., Pepine C.J., Rickens C.R., Reichek N., Rogers W.J., et al. Large brachial artery diameter is associated with angiographic coronary artery disease in women. Am Heart J 143 (2002) 802-807
18. Bonithon-Kopp C., Touboul P.J., Berr C., Magne C., and Ducimetiere P. Factors of carotid arterial enlargement in a population aged 59 to 71 years: the EVA study. Stroke 27 (1996) 654-660
19. Kiechl S., and Willeit J. The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group. Arterioscler Thromb Vasc Biol 19 (1999) 1491-1498
20. Crouse J.R., Herrington D.M., and Espeland M.A. Arterial diameter is increased and flow-mediated brachial artery vasodilation is impaired in individuals olden than 70 with cardiovascular disease. The Cardiovascular Health Study. Circulation 102 (2000) 836
21. Mondy K.E., de las Fuentes L., Waggoner A., Onen N.F., Bopp CS Lassa-Claxton S., Powderly W.G., et al. Insulin resistance predicts endothelial dysfunction and cardiovascular risk in HIV-infected persons on long-term highly active antiretroviral therapy. AIDS 22 (2008) 849-856
22. Lerman A., and Zeiher A.M. Endothelial function: cardiac events. Circulation 111 (2005) 363-368
23. Rossi R., Nuzzo G., Origliani G., and Modena M.G. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol 51 (2008) 997-1002
24. Yeboah J., Crouse J.R., Hsu F.C., Burke G.L., and Herrington D.M. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults. The Cardiovascular Health Study. Circulation 115 (2007) 2390-2397
25. Shimbo D., Grahame-Clarke C., Miyake Y., Rodriguez C., Sciacca R., Di Tullio M., et al. The association between endothelial dysfunction and cardiovascular outcome in a population-based multi-ethnic cohort. Atherosclerosis 192 (2007) 197-203
26. Hata A., Reid C.L., Ogata T., Tukushima T., and Gardin J.M. Reproducibility of brachial artery ultrasound measurements. Echocardiography 6 (1999) 367-372